中国全科医学 ›› 2020, Vol. 23 ›› Issue (26): 3274-3279.DOI: 10.12114/j.issn.1007-9572.2020.00.057

所属专题: 心房颤动最新文章合集 心血管最新文章合集

• 专题研究 • 上一篇    下一篇

心血管疾病合并心房颤动与慢性肺疾病合并心房颤动患者的临床特征研究

刘湘,项丽,张岚,佟光明*   

  1. 215004江苏省苏州市,苏州大学附属第二医院心血管内科
    *通信作者:佟光明,主任医师;E-mail:tgm1@sina.com
  • 出版日期:2020-09-15 发布日期:2020-09-15
  • 基金资助:
    基金项目:苏州市科技计划项目(SYS201721)

Clinical Characteristics of Patients with Cardiovascular Disease and Chronic Pulmonary Disease Complicated with Atrial Fibrillation 

LIU Xiang,XIANG Li,ZHANG Lan,TONG Guangming*   

  1. Department of Cardiology,the Second Affiliated Hospital of Soochow University,Suzhou 215004,China
    *Corresponding author:TONG Guangming,Chief physician;E-mail:tgm1@sina.com
  • Published:2020-09-15 Online:2020-09-15

摘要: 背景 心房颤动是脑梗死的独立危险因素。近年来随着新型抗凝药物的引进,心血管疾病合并心房颤动者的抗凝比例逐渐升高,脑梗死发生率较前下降;但是,慢性肺疾病合并心房颤动患者脑梗死发生率和抗凝治疗现状的研究相对缺乏。目的 探讨同期住院心血管疾病与慢性肺疾病合并心房颤动患者的临床特征及远期脑梗死发生率的差异,评估慢性肺疾病合并心房颤动者脑梗死的发生率及抗凝现状,以期对该类患者进行早期干预,改善预后。方法 前瞻性连续选取2012年6月—2013年5月入住苏州大学附属第二医院的持续性或永久性心房颤动患者287例为研究对象。根据合并的主要疾病将研究对象分为心血管病组(合并心血管疾病,n=162)和肺病组(合并慢性肺疾病,n=125),记录患者一般资料、入院次日清晨血液检查、超声心动图数据及CHA2DS2-VASc评分。后续对患者进行为期5年的随访,记录随访期间患者抗凝等药物使用情况和脑梗死发生情况。结果 肺病组患者年龄、男性比例、静息心率、心力衰竭比例、右心房内径(RAD)长径、RAD短径、基底段右心室内径(RVD)、肺动脉压力、凝血酶原时间(PT)、D-二聚体、国际标准化比值(INR)、N末端脑钠肽前体(NT-proBNP)、CHA2DS2-VASc评分、CHA2DS2-VASc评分≥4分的比例高于心血管病组(P<0.05);凝血酶Ⅲ水平低于心血管病组(P<0.05)。两组抗凝药使用情况比较,差异无统计学意义(P=0.208);心血管病组使用氯吡格雷、血管紧张素转换酶抑制剂(ACEI)/血管紧张素Ⅱ受体拮抗剂(ARB)类、胺碘酮药物比例高于肺病组(P<0.05)。随访期间,心血管病组共发生脑梗死16例(9.9%),肺病组29例(23.2%),两组比较,差异有统计学意义(χ2=9.477,P=0.002)。多因素Logistic回归分析结果显示,年龄、CHA2DS2-VASc评分、RAD短径、肺动脉压力是心房颤动患者发生脑梗死的影响因素(P<0.05)。结论 同期住院慢性肺疾病合并心房颤动患者远期脑梗死发生率高;慢性肺疾病合并心房颤动人群较心血管疾病合并心房颤动人群存在较高的CHA2DS2-VASc评分、RAD、RVD及肺动脉压力;针对慢性肺疾病合并心房颤动患者,应及时评估抗凝指征,加强相应的治疗方案,同时重视心力衰竭、肺炎等合并症的治疗。

关键词: 心房颤动, 心血管疾病, 肺疾病, 脑梗死, 疾病特征, 危险因素

Abstract: Background Atrial fibrillation is an independent risk factor for cerebral infarction.With the introduction of new anticoagulants in recent years,the anticoagulation ratio in patients with cardiovascular disease and atrial fibrillation has gradually increased,and the incidence of cerebral infarction shows the downward trend.However,relatively few reports on the incidence of cerebral infarction and current status of anticoagulant therapy in chronic pulmonary patients with atrial fibrillation are available.Objective To explore the clinical characteristics of patients with cardiovascular disease and chronic pulmonary disease complicated with atrial fibrillation in the same period of admission and the incidence of long-term cerebral infarction among them,and to evaluate the incidence of cerebral infarction and anticoagulation status in patients with chronic pulmonary disease and atrial fibrillation,in order to provide the early intervention and improve the prognosis.Methods 287 Patients with persistent or permanent atrial fibrillation admitted to the Second Affiliated Hospital of Soochow University were selected prospectively and continuously as the study subjects from June 2012 to May 2013.According to the main complications,the subjects were divided into the cardiovascular disease group(combined with cardiovascular diseases,n=162) and the lung disease group(combined with chronic pulmonary diseases,n=125).The general data of patients,blood examination results in the early morning of the day after admission,echocardiographic data and CHA2DS2-VASc scores were recorded.The patients were followed up for a period of five years,and the use of anticoagulants and the incidence of cerebral infarction were recorded.Results The age,proportion of male,resting heart rate,heart failure proportion,right atrial long axis diameter,right atrial short axis diameter,right ventricular diameter(RVD) of basal segment,pulmonary artery pressure,prothrombin time(PT),D-dimer,international normalized ratio(INR),NT-proBNP,CHA2DS2-VASc scores and proportion of CHA2DS2-VASc scores≥4 in the lung disease group were higher than those in the cardiovascular disease group,while the level of thrombin Ⅲ was lower(P<0.05).There was no significant difference in the use of anticoagulants between the two groups(P=0.208).The proportion of clopidogrel,ACEI/ARB and amiodarone in the cardiovascular disease group was higher than that in the lung disease group(P<0.05).During five consecutive years of follow-up,16(9.9%) patients in the cardiovascular disease group and 29(23.2%) patients in the lung disease group suffered from cerebral infarction.The difference between the two groups was statistically significant(χ2=9.477,P=0.002).Multivariate Logistic regression analysis showed that age,CHA2DS2-VASc scores,right atrial short axis diameter and pulmonary artery pressure were the risk factors of cerebral infarction in patients with atrial fibrillation(P<0.05).Conclusion The incidence of long-term cerebral infarction in patients with chronic pulmonary disease and atrial fibrillation is high during the same period of admission,and these patients have high CHA2DS2-VASc scores,right atrial diameter(RAD),RVD and pulmonary artery pressure.For patients with chronic pulmonary disease and atrial fibrillation,anticoagulation indications should be evaluated in time,and corresponding treatment schemes should be strengthened,and the treatment of comorbidities such as heart failure and pneumonia should be emphasized.

Key words: Atrial fibrillation, Cardiovascular diseases, Lung diseases, Cerebral infarction, Disease attributes, Risk factors